MedPath

Belpharma Sa

🇧🇪Belgium
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

2

EMA:1
CIMA_AEMPS:1

Drug Approvals

Beromun

Authorization Status
Authorised
Approval Date
Apr 12, 1999
EMA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae

Phase 4
Withdrawn
Conditions
Urinary Tract Infection
Interventions
First Posted Date
2012-03-05
Last Posted Date
2013-01-29
Lead Sponsor
Belpharma s.a.
Registration Number
NCT01543347
Locations
🇬🇧

Birmingham Heartlands Hospital, Birmingham, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.